Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of chimeric antigen receptor and its application

A chimeric antigen receptor and nanobody technology, applied in the field of tumor cell immunotherapy, can solve problems such as unsatisfactory effect

Active Publication Date: 2021-10-22
THE SECOND PEOPLES HOSPITAL OF SHENZHEN +1
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Current treatment methods include chemotherapy, proteasome inhibitors, immunomodulators, monoclonal antibodies, and hematopoietic stem cell transplantation, etc., but the effect is still unsatisfactory. CAR-T cells are expected to become a new method for the treatment of MM

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of chimeric antigen receptor and its application
  • A kind of chimeric antigen receptor and its application
  • A kind of chimeric antigen receptor and its application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] Example 1: Determination of CD38Nb-CD8α-CD137-CD3ζ gene sequence and construction of lentiviral expression plasmid

[0027] 1.1 Immunize alpaca with human CD38 protein and screen with phage display technology to obtain anti-human CD38 nanobody sequence. Human CD8α signal peptide (NM_001145873), human CD8α hinge region and transmembrane region (NM_001145873), human CD137 intracellular region (NM_001561) and human CD3ζ intracellular region (NM_198053) gene sequences. The Myc tagged protein is the commonly used 10 amino acid "EQKLISEEDL".

[0028] 1.2 The above gene sequence was sequenced according to human CD8α signal peptide gene, Myc tag sequence, anti-human CD38 nanobody sequence, human CD8α hinge region and transmembrane region gene, human CD137 intracellular region gene, and human CD3ζ intracellular region gene sequence Link, and introduce Kozac sequence at the N-terminus, and introduce different enzyme cutting sites at the junction of each sequence to form the com...

Embodiment 2

[0030] Example 2: Packaging, concentration and titer determination of lentivirus

[0031] A large number of plasmids were extracted by alkaline lysis (Beijing Tiangen Biochemical Technology Co., Ltd. Endotoxin-free plasmid extraction kit), and the lentivirus packaging kit (including lentivirus packaging mixture and HET high-efficiency transfection reagent) of Baienwei Biotechnology Co., Ltd. box) transfected 293T cells packaging virus.

[0032] 2.1 Packaging and concentration of lentivirus:

[0033] 1) On the day before transfection, prepare cells for passage: digest 293T cells with 0.25% trypsin, adjust the cell density with DMEM medium containing 10% serum, and inoculate 6-8×10 cells per 10 cm cell culture dish. 6 Cells into a 10 cm cell culture dish at 37 °C, 5% CO 2 Cultivate in an incubator, and transfect when the cell density grows to 80%-90% after 16h-24h.

[0034] 2) On the next day, 2h-4h before transfection, replace the medium with 5ml P / S-free medium (DMEM+10%FBS)....

Embodiment 3

[0051] Example 3: Preparation and identification of anti-human CD38-CAR-T cells

[0052] 3.1 Isolation, purification and stimulating culture of T cells

[0053] Take peripheral blood from healthy donors, add 50μl of RosetteSep to each 1ml sample TM Human T cell enrichment antibody mixture, mix well; incubate at room temperature for 20min; add an equal volume of PBS+2%FBS to dilute the above sample and carefully add to the upper layer of Ficoll separation medium; centrifuge at 1,200g room temperature for 20min; absorb the middle layer of white membrane on in a centrifuge tube; wash the cells twice with PBS+2% FBS, centrifuge at 1,500rpm for 10min; use X-VIVO containing 5% FBS for the cell pellet TM 15 Resuspended in the culture medium, stained with trypan blue and counted; used X-VIVO magnetic beads for anti-human CD3 / CD28 TM 15 culture medium was washed twice, added to the T cell suspension at a ratio of 1:1, and the cell density was adjusted to 1×10 6 / ml, and 100IU / ml rhI...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a nanobody-based chimeric antigen receptor CD38Nb-CD8α-CD137-CD3ζ and an application thereof. The chimeric antigen receptor comprises anti-human CD38 nanobody, human CD8α hinge region and transmembrane region, human CD137 intracellular region and CD3ζ intracellular region sequentially connected in series. The chimeric antigen receptor is used to modify T lymphocytes, and the modified T cells (CAR-T cells) can be used for the treatment of surface CD38-positive tumors.

Description

technical field [0001] The present invention relates to the field of tumor cell immunotherapy, in particular to a CD38Nb-CD8α-CD137-CD3ζ chimeric antigen receptor in serial series and its application in the preparation of CAR-T cells and tumor treatment. Background technique [0002] In recent years, studies have found that the single-chain variable region (scFv) of a tumor-specific monoclonal antibody replaces the α and β chain variable regions of TCR, and the scFv directly interacts with co-stimulatory molecules (such as CD28, CD137, etc.) and T cell signaling. The conduction region CD3ζ is connected to form a chimeric antigen receptor (CAR) expressed on the surface of T cells, which can recognize tumor-specific antigens through scFv, directly generate the first and second signals of T cell activation, and promote T cell activation and proliferation. sexually kill tumor cells. This process mainly depends on the specific recognition of tumor antigens by the scFv on the sur...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K19/00C12N15/62C12N5/10A61P35/00
CPCA61K35/17C07K14/7051C07K16/2896C07K2317/569C07K2319/02C07K2319/03C07K2319/33C07K2319/41
Inventor 杜新赵永娟张巧霞安娜侯运楠黎婷
Owner THE SECOND PEOPLES HOSPITAL OF SHENZHEN